Back
Xeris Biopharma Holdings, Inc. Stock Price Chart
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
64
XERS
Xeris Biopharma Holdings, Inc.
Last Price:
$6.72
Seasonality Move:
1.07%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
The current trend is moderately bullish and XERS is experiencing slight selling pressure.
Xeris Biopharma Holdings, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.92 | Sell |
| 20-day SMA: | 7.14 | Sell |
| 50-day SMA: | 8.14 | Sell |
| 200-day SMA: | 6.07 | Buy |
| 8-day EMA: | 6.76 | Sell |
| 20-day EMA: | 5.69 | Buy |
| 50-day EMA: | 3.46 | Buy |
| 200-day EMA: | 1.1 | Buy |
Xeris Biopharma Holdings, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.41 | Buy |
| Relative Strength Index (14 RSI): | 35 | Sell |
| Chaikin Money Flow: | -610365 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.57 - 8.79) | Sell |
| Bollinger Bands (100): | (6.24 - 8.76) | Sell |
Xeris Biopharma Holdings, Inc. Technical Analysis
| Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Xeris Biopharma Holdings, Inc. Stock
Is Xeris Biopharma Holdings, Inc. Stock a Buy?
-
Xeris Biopharma Holdings, Inc. share price is 6.72 while XERS 8-day simple moving average is 6.92, which is a Sell signal.
-
The stock price of XERS is 6.72 while Xeris Biopharma Holdings, Inc. 20-day SMA is 7.14, which makes it a Sell.
-
Xeris Biopharma Holdings, Inc. 50-day simple moving average is 8.14 while XERS share price is 6.72, making it a Sell technically.
-
XERS stock price is 6.72 and Xeris Biopharma Holdings, Inc. 200-day simple moving average is 6.07, creating a Buy signal.
XERS Technical Analysis vs Fundamental Analysis
Buy
64
Xeris Biopharma Holdings, Inc. (XERS)
is a Buy
Is Xeris Biopharma Holdings, Inc. a Buy or a Sell?
-
Xeris Biopharma Holdings, Inc. stock is rated a BuyThe current Xeris Biopharma Holdings, Inc. [XERS] share price is $6.72. The Score for XERS is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
Xeris Biopharma Holdings, Inc. Stock Info
Market Cap:
1.1B
Price in USD:
6.72
Share Volume:
1.4M
Xeris Biopharma Holdings, Inc. 52-Week Range
52-Week High:
10.08
52-Week Low:
3.14
Buy
64
Xeris Biopharma Holdings, Inc. (XERS)
is a Buy
Xeris Biopharma Holdings, Inc. Share Price Forecast
-
What is the Xeris Biopharma Holdings, Inc. stock price today?The Xeris Biopharma Holdings, Inc. stock price is 6.72 USD today.
-
Will XERS stock go up or go down?Xeris Biopharma Holdings, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Xeris Biopharma Holdings, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Xeris Biopharma Holdings, Inc. is not overvalued.
Is Xeris Biopharma Holdings, Inc. Stock a Buy?
-
Xeris Biopharma Holdings, Inc. share price is 6.72 while XERS 8-day exponential moving average is 6.76, which is a Sell signal.
-
The stock price of XERS is 6.72 while Xeris Biopharma Holdings, Inc. 20-day EMA is 5.69, which makes it a Buy.
-
Xeris Biopharma Holdings, Inc. 50-day exponential moving average is 3.46 while XERS share price is 6.72, making it a Buy technically.
-
XERS stock price is 6.72 and Xeris Biopharma Holdings, Inc. 200-day simple moving average is 1.10, creating a Buy signal.
Fundamental Analysis of Xeris Biopharma Holdings, Inc.
Is Xeris Biopharma Holdings, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.21 per share, and an increase next year of $0.35 per share.
Technical Analysis of Xeris Biopharma Holdings, Inc.
Should I short Xeris Biopharma Holdings, Inc. stock?
-
XERS Moving Average Covergence Divergence (MACD) indicator is 1.41, suggesting Xeris Biopharma Holdings, Inc. is a Buy
-
Xeris Biopharma Holdings, Inc. Relative Strength Index (RSI) is 35, which suggest Xeris Biopharma Holdings, Inc. is oversold
-
The Bollinger Bands (25) for Xeris Biopharma Holdings, Inc. is (6.57 - 8.79), which suggest Xeris Biopharma Holdings, Inc. is a Sell
-
The Bollinger Bands (100) for Xeris Biopharma Holdings, Inc. is (6.24 - 8.76), which suggest Xeris Biopharma Holdings, Inc. is a Sell
* Xeris Biopharma Holdings, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.